No abstract available
MeSH terms
-
Adult
-
Antipsychotic Agents / adverse effects*
-
Antipsychotic Agents / therapeutic use
-
Cardiovascular Diseases / chemically induced
-
Cardiovascular Diseases / epidemiology
-
Cardiovascular Diseases / mortality
-
Cause of Death
-
Diabetic Ketoacidosis / chemically induced
-
Diabetic Ketoacidosis / epidemiology
-
Diabetic Ketoacidosis / mortality
-
Drug Monitoring
-
Female
-
Humans
-
Hyperlipidemias / chemically induced
-
Hyperlipidemias / epidemiology
-
Hyperlipidemias / mortality
-
Insulin Resistance
-
Male
-
Metabolic Syndrome / chemically induced*
-
Metabolic Syndrome / epidemiology
-
Metabolic Syndrome / mortality
-
Myocardial Infarction / chemically induced
-
Myocardial Infarction / epidemiology
-
Myocardial Infarction / mortality
-
Obesity / chemically induced*
-
Obesity / epidemiology
-
Obesity / mortality
-
Prevalence
-
Risk Factors
-
Schizophrenia / drug therapy*
-
Schizophrenia / mortality*
-
Weight Gain / drug effects*